HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intralesional Cidofovir application in recurrent laryngeal papillomatosis.

Abstract
Recurrent laryngeal papillomatosis is a benign disease of the larynx often leading to organic and functional restrictions. The therapeutic treatment of choice in larynx-obstructing papillomatosis is at present surgical laser ablation. The effectiveness of adjuvant intralesional injection of the virustaticum Cidofovir has been investigated recently in a variety of therapeutic models. The present case study deals with the treatment of recurrent laryngeal papillomatosis by means of surgical laser ablation of the laryngeal papillomas with adjuvant local injection of the virustaticum Cidofovir (dose of 5 mg/1 ml). Within the period from October 2001 to August 2004, ten patients aged between 5- and 70 years were treated with intralesional injections of Cidofovir. Papillomatosis was confirmed histologically in all cases, and the virus types were defined in part. Each of the patients underwent clinical-phoniatric examinations and was photographed for documentation. After 2-7 treatments with surgical laser papilloma ablation and intralesional Cidofovir injections, all patients showed a definite papilloma reduction, while in six cases complete remission was achieved. During the follow-up period of 8-30 months, not a single recurrence of the laryngeal papillomatosis occurred. In the majority of patients, a clear improvement in the voice was achieved. There were no local or systemic side effects caused by the virustaticum. Intralesional injection of Cidofovir is an adjuvant, but not a curative therapeutic option in recurrent laryngeal papillomatosis. Remission of previously frequently recurrent laryngeal papillomas can be achieved, but recurrence after longer treatment-free intervals is also possible.
AuthorsAnnett Pudszuhn, Cornelia Welzel, Marc Bloching, Kerstin Neumann
JournalEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (Eur Arch Otorhinolaryngol) Vol. 264 Issue 1 Pg. 63-70 (Jan 2007) ISSN: 0937-4477 [Print] Germany
PMID17058091 (Publication Type: Journal Article)
Chemical References
  • Antiviral Agents
  • Organophosphonates
  • Cytosine
  • Cidofovir
Topics
  • Adult
  • Aged
  • Antiviral Agents (therapeutic use)
  • Child, Preschool
  • Cidofovir
  • Combined Modality Therapy
  • Cytosine (analogs & derivatives, therapeutic use)
  • Female
  • Human papillomavirus 11 (isolation & purification)
  • Human papillomavirus 6 (isolation & purification)
  • Humans
  • Laryngeal Mucosa (pathology, virology)
  • Laryngeal Neoplasms (drug therapy, pathology, surgery)
  • Laser Therapy
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Neoplasm Staging
  • Organophosphonates (therapeutic use)
  • Papilloma (drug therapy, pathology, surgery)
  • Remission Induction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: